Jeffrey Chiprin

Jeffrey Chiprin

Chief Commercial OfficeratIradimed· In proxies 2023–2025

Pay in FY2025+36% from the year before · Iradimed stock +76.9% the same year

Jeffrey Chiprin was paid $529.4K in FY2025 (Dec), up 36%. Iradimed stock rose 76.9% that year.

Pay$100 in the stock at the end of FY22 → $344
Pay is from the Summary Compensation Table of each Iradimed proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IradimedPublic company · 3 yr
    • Chief Commercial Officer2023 – Present · 3 yrStock in role +199%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?